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Cerebral microhemorrhages (CMBs) are small hemorrhagic strokes found in the brain, 
also known as silent stroke since they do not illicit noticeable symptoms. Recently, 
due to the development of various imaging modalities and aging population in the 
western world, increasing number of CMBs are detected. Clinical studies have shown 
that aging and hypertension significantly increases the chance of such bleeds and the 
National Institute of Health recognizes CMBs as a major factor in Alzheimer disease 
pathology. Independent events of CMBs are also a risk factor for subsequent larger 
intracerebral hemorrhages, ischemic stroke, Binswager’s disease and Alzheimer’s 
disease. However, studies in cellular level are lacking, partially due to inadequate 
animal model that allow both detection and follow up analysis of such small bleeds. 
We used tightly focused femtosecond laser pulses to injure single penetrating 
arterioles in the cortex of live anesthetized rodents and used multi-photon excited 
fluorescence imaging to quantify inflammatory responses over long periods of time. 
The work presented in this dissertation provides comprehensive spatial and temporal 
pathological consequences after micro scale hemorrhagic injury to a single blood 
vessel in the brain. 
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CHAPTER ONE 
 
INTRODUCTION AND ORGANIZATION OF DISSERTATION 
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1.1 Introduction  
The work described in this dissertation involves the study of neuropathology using 
various optical methods to modulate and/or observe various structures in the brain. Each 
chapter can be read independently.  
 
Chapter 2 
This chapter provides an introduction on nonlinear imaging, specifically multi-photon 
excited fluorescence used for in vivo imaging in this dissertation. The chapter describes 
the physics behind multi-photon excited fluorescence, its advantage over single photon 
excited fluorescence imaging, implications in biological research and its applications. 
This chapter also introduces higher harmonic generations and femtosecond laser induced 
ionization techniques to rupture a blood vessel or selectively ablate targeted cell types in 
the brain. 
 
Chapter 3 
This chapter introduces cerebral microbleeds by compiling recent literature. Topics range 
from the definition of cortical microbleeds, how they are detected, clinical implications, 
and the underlying pathophysiology at the cellular and systemic level. 
 
Chapter 4 
This chapter provides a comprehensive picture of the inflammatory response following 
microhemorrhage. This chapter primarily focuses on the identification of major 
inflammatory cell types and their spatiotemporal dynamics following lesions. To 
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understand the mechanisms leading to increased inflammatory cell density near the 
lesion, a computational simulation is presented to further understand the coordinated 
pattern of cell migration and proliferation due to microhemorrhage. 
 
Chapter 5 
This chapter introduces label free measurement of cortical blood cell speed using third 
harmonic generation (THG) microscopy. A comparison of blood cell speed with and 
without a vascular fluorescent dye measured by line scan technique is presented. 
 
Chapter 6 
This chapter explores the influence of the apolipoprotein E4 (ApoE4) on blood flow 
within the corpus callosum white matter. Using three-photon fluorescence microscopy 
with third harmonic generation, we measure blood cell speed in the capillaries located in 
the white matter. We demonstrate that the expression of ApoE4 decreases blood flow in 
the white matter that is exacerbated with a model of diffuse white matter injury. 
 
Chapter 7  
This chapter provides a summary of important findings presented by this thesis. Possible 
future directions to further define the influence of blood flow alterations to the 
pathophysiology of the brain, are also discussed.  
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CHAPTER TWO 
 
NONLINEAR OPTICAL METHODS TO IMAGE AND MANIPULATE 
BIOLOGICAL SYSTEMS 
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2.1 Multiphoton Microscopy for Biological Studies  
 Over the past decades, along with the advances in the molecular biology, 
genomics and proteomics revolutions, optical microscopy has become one of the most 
important research tool used in biomedical research [1]. For example, genetic targeting 
strategies can express structural and functional fluorescent proteins with cellular 
specificity in a living animal. These proteins can yield highly-quantitative data which 
indirectly probe molecular kinetics, pH, and calcium transients to using the emitted 
fluorescent signal. Therefore, the multiphoton microscope has become the go to tool to 
answer quantitative biological questions. Nonlinear microscopy gains multiple 
advantages over linear confocal microscopy through restricting the fluorescence 
excitation volume, rather than restricting the fluorescence collection to localize the 
fluorescent signal in space, allowing for optical sectioning. This efficiency allowed deep 
imaging through scattering tissue with high resolution and contrast and lowers the chance 
of photo bleaching and secondary laser induced damage. Therefore, the advent of 
nonlinear microscopy opened an era of imaging living animals in a minimally invasive 
way to study the cellular structures and processes, allowing study of their response to 
systematic manipulations in their natural environment. 
 
2.1.1  Multiphoton Excitation Fluorescence 
Fluorescence occurs when a fluorophore absorbs a photon, raising an electron to 
an excited energy state, from which it relaxes back to the electronic ground state and 
emits a lower energy photon. The absorption occurs when the energy of a laser photon is 
equal to or greater than the energy difference between the two states. The minimum 
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energy that can transit a fluorophore from ground state to higher excited state depends on 
the nature of fluorophore, and this energy can be given by a single or by multiple 
photons. The energy of a photon is inversely proportional to its wavelength ( , 
where h is Planck’s constant, c is speed of light, and λ is wavelength). Thus,, multiple 
photons of longer wavelengths can generate the same amount of energy as a single 
photon of shorter wavelength.  
Two-photon excitation fluorescence (2PEF) refers to the excitation of a 
fluorophore when two photons arrive within a time window of an attosecond (10-18 s) and 
excite a fluorescent molecule [2]. Any combination of photons of with the net sum can 
work, but for practical reasons, two photons of same energy are typically used. The same 
principle applies to three-photon excitation fluorescence (3PEF), by simultaneously using 
three photons to team up to excite one molecule. Multi-photon excitation fluorescence 
(MEF) requires extremely high photon flux for simultaneous absorption of multiple 
photons to achieve fluorescence. To achieve sufficient MEF while preserving the 
integrity of biological tissue, pulsed light is used. A mode locked laser can emits 
intermittently in high intensity bursts rather than in a continuous beam. Generally, 
picosecond to femtosecond duration pulses with low repetition rate (<100 MHz) is used 
for excitation source. Furthermore, the 3PEF excitation volume is more tightly focused 
than 2PEF as 3PEF falls off from the focal plane as ~ 1/z4 (z is the distance), while 2PEF 
falls off as ~ 1/z2 [3]. The pulsed laser beam is spatially constrained to a diffraction-
limited volume by using a high-numerical aperture (NA) microscope objective. When a 
laser beam is tightly focused inside a fluorescent sample, the peak intensity will be at the 
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focus and thus the resulting image will have less out-of-focus background in regions far 
away from the focal plane.  
 
2.1.2 Harmonic Generation 
 Harmonic generation is a coherent (phase-preserving) process that requires no 
actual absorption but generates output signal near a resonant material. Optical harmonic 
generation uses two or three photons simultaneously to create a single photon of exactly 
twice (or triple, based on the order of the harmonic) the incoming energy from the 
excitation photon. Therefore, the laser-induced harmonic generation (HG) deposits no 
energy in the material. It can provide noninvasive optical imaging ideal for some clinical 
uses [4]. HG utilizes endogenous structure in a biological sample (label-free imaging) 
and doesn’t require a fluorophore to generate a signal; it can avoid common issues of 
fluorescence excitation, such as photodamage, phototoxicity, photobleaching, and dye 
toxicity. HG in biological imaging includes second harmonic generation (SHG), and third 
harmonic generation (THG) based on the material properties, both can be generated with 
a sufficiently compressed laser pulse.  
The following second order equation can describe SHG, where  is 
the susceptibility tensor that converts two photons of incoming energy and frequency into 
a single photon at twice the frequency,  is the coefficient for only highly organized 
non-centrocymmetric molecule,  is the laser field amplitude, and  is the 
polarization.  
 
Similarly, THG is generated based on  
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In case of THG, the signal generated is proportional to the  tensor and 
unlike SHG, all materials have a non-vanishing coefficient, which varies according to 
material properties and wavelength. According to the equations above, the generated HG 
intensity depends on the square (SHG) and cube (THG) of the incident light intensity. 
Similar to MEF, HG provides high spatial resolution and signal to noise ratio due to its 
quadratic and cubic dependencies on incident intensities [5]. 
 
2.1.3 Multi-Photon Microscopy 
  To increase the nonlinearly generated signal, it is important to use laser source 
that generates high peak power pulses. One advantage of multiphoton microscopy is that 
many fluorophores possess broad multi-photon excitation spectra [6]. In other words, 
several fluorophores and even harmonic generation can be excited at the same time with 
the same laser source if laser is set at a wavelength that covers the multi-photon cross 
section of all nonlinear events.  
 Multi-photon microscopy is designed to deliver laser pulse into highly scattering 
biological tissue and efficient signal collection. First, beam size is adjusted through scan 
lens and tube lens so that the beam can fully cover the back aperture of the microscope 
objective. High NA objectives spatially focus pulsed-laser photons to generates MEF 
and/or HG at the focus, which travels back through the same objective. Emission signal 
from the specimen then gets routed to detection optics by a long pass primary dichroic 
which reflects shorter wavelength signals. Additional dichroic mirrors are required to 
spectrally separate emitted light into multiple channels. Light separated by dichroic 
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mirrors is further filtered by a band pass filter to select for a more narrow wavelength 
range and then gets detected onto a photomultiplier tube (PMT). PMT signals are 
digitally converted and arranged into an imaging frame. A schematic of the multi-photon 
microscope used to acquire data presented in this thesis is shown in Figure 2.1. 
 
2.2 Laser Ablation 
 Another application of nonlinear optics is to physically manipulate an biological 
material by multi-photon ionization [7]. Just like in MEF, multiple photons can be 
absorbed from a tightly focused intense pulse of laser light and excite electrons from the 
valence band into the conduction band. The energy applied here should be equal to or 
greater than the band-gap minimum of the material of interest.  
 When laser intensity at the focus is sufficiently high, the electron in the 
conduction band can be elevated to an even higher state. This electron can then collide 
with electron in the valence band and transfer some of its energy so that both electrons 
can stay in the conduction band (donor electron must have energy greater than the band-
gap minimum). Following the initial ionization, a series of ionization events can follow 
until all energy around is depleted. This cumulative ionization process is called avalanche 
ionization. Ionization leads to a high-density electron-ion plasma. This is followed by a 
pressure wave and a cavitation bubble that can damage a material in addition to the 
effects of ionization. With precise tuning of laser pulse energy and focusing through a 
microscope objective, the size of cavitation bubble can be confined at the focal point. The 
degree and size of femtosecond laser induced damage can be controlled through choosing 
focusing energy and number of pulses. 
! 10!
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Figure 2.1 Schematic of four channel multi-photon microscopy equipped with 
femtosecond laser ablation 
 
The work presented in this thesis utilized this laser-induced ionization to create 
small hemorrhages of cortical blood vessels in vivo [8]. Combined with multi-photon 
microscopy with four detection channels, we were able to study the response of multiple 
cellular populations to small bleeds in the brain.  The ablation laser was collinearly 
aligned with the laser used for multiphoton microscopy after galvanometric scanners so 
that the ablation is fixed at relative to the induced imaging raster scan. This experimental 
setting allowed us to both induce and visualize the expansion of a hematoma as it was 
created.  
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CEREBRAL MICROHEMORRHAGES 
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3.1 Cerebral Microhemorrhages 
 Cerebral microhemorrhages or cortical microbleeds (CMBs) are small, up to 
10mm in diameter, hemorrhagic strokes found in the brain. CMBs are often called as 
silent strokes since they don’t illicit noticeable acute symptoms. These small injuries are 
mostly due to bleeding from small arterioles and capillaries. The development of various 
imaging modalities lead to increasing detections of CMBs are detected. Clinical studies 
have shown that aging and hypertension significantly increases the chance of such 
bleedings, and the National Institute of Health recognizes CMBs as a major factor in 
Alzheimer disease (AD) pathology. CMBs are also a risk factor for subsequent larger 
intracerebral hemorrhages, ischemic stroke, Binswager’s disease, and AD. Therefore, 
more research needs to be done in both clinics and basic research settings to understand 
the pathophysiology of CMBs. 
 
3.1.1 Diagnosis 
In clinical practice, primarily to exclude hemorrhage and other pathologies such as brain 
tumors, computed tomography (CT) is primarily performed. CT can effectively show 
early signs of ischemia (e.g., swelling, changes in vessel density) and previous stroke 
lesions. However, magnetic resonance imaging (MRI) is preferred to CT for research and 
routine clinical use for screening since MRI features higher sensitivity and specificity for 
detecting pathological changes [1]. CMBs can be detected on a conventional MRI at 1.5T 
or 3T (higher the better) in T1- and T2-weighted spin echo images, but most are evident 
on T2*- weighted gradient recalled echo (GRE). CMBs appear as small round or ovoid 
homogeneous foci of black or hypointensity (ie, signal voids) on T2*-weighted GRE [2, 
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3]. After extravasation of erythrocytes into the parenchyma, various inflammatory 
responses degrade hemoglobin in erythrocytes and form hemosiderin, which is 
paramagnetic. Therefore, CMBs are effectively detected with MRI sequence 
susceptibility-weighted imaging (SWI), which is highly sensitive in detecting blood 
products, through the distortion of magnetic fields by calcium and hemosiderin deposits. 
CMBs are classified using a variety of size cut-off points with a maximum diameter of 5–
10 mm and a minimum diameter of 2 mm, since the size of a CMB shown on MRI 
critically depends on imaging parameters, such as field strength and sequence [4]. In a 
clinical setting, this upper size limit is used to distinct CMBs from larger bleeds 
(macrobleeds). In a small number of studies that compared imaging and pathology, near-
microscopic (<1–2 mm diameter) clusters of perivascular hemosiderin-laden 
macrophages were found around small perforating vessels in the histological counterparts 
of MRI imaging [5]. Other feasible pathologies that generate similar MRI signals are old 
hematomas, intact erythrocytes and, vascular pseudocalcification, microaneurysm, and 
distended dissected vessels [6]. These MRI detectable bleeds can be seen in up to 65% of 
patients diagnosed with vascular dementia [7]. Further advances in high-resolution novel 
imaging methods and clinical studies with extensive follow-up MRI scans will provide 
better understanding of the clinical consequences and the pathogenesis of currently under 
diagnosed CMBs. 
 
3.2 Clinical Significance  
3.2.1  Epidemiology and Risk Factors 
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Age is the most significant and independent risk factor for CMBs, with the prevalence 
gradually increase with age [8, 9]. Approximately half of the populations diagnosed with 
CMBs present multiple incidents [10]. Across multiple studies, the prevalence of CMBs 
in the elderly patients ranges between 24%~56% [8, 10-12]. Cardiovascular risk factors 
(ie, high systolic blood pressure, hypertension, smoking) and presence of cardiovascular 
disease are also linked to the presence of CMBs [8]. Lacunar ischemic stroke and patients 
with intracranial hemorrhages also present high incidence of small bleeds [13]. About 
half of the individuals suffering cerebral autosomal-dominant arteriopathy (CADASIL) 
with subcortical infarcts and leukoencephalopathy, caused by mutations of the Notch-3 
gene also have CMBs [14]. Interestingly apolipoprotein (ApoE)  carriers are reported 
to have lobular CMBs in both younger and older population [8, 15]. Patients under 
anticoagulants and antithrombotic drugs have also reported higher incidence of CMBs 
[16]. CMBs detection is expected to further increase due to the rapid development and 
increasing availability of imaging methods.  
 
Figure 3.1 Distribution and the topography of cerebral microbleeds (CMBs). (figure 
from [17] used under Creative Common Attribution (CC BY version 4.0)) 
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Cerebral amyloid angiopathy (CAA) and hypertension are the two major disease 
phenotypes directly linked to cause CMBs (Figure 3.1). Vessel stiffening due to CAA is 
known to correlate with cortical/subcortical lobar CMBs in CAA patients [18]. 
Hypertension is a major risk factor for CMBs and correlates with incidence in the elderly 
[9, 15, 19]. Where CMBs are located reflects the underlying small vessel disease. Strictly 
lobar CMBs are related to bleeding ensued from CAA pathology, while deep CMBs are 
due to hypertensive arteriopathy (Figure 3.1) [20-22]. CMBs due to hypertensive 
arteriopathy are also extensively found in the elderly.  
CMBs are thought as the asymptomatic predecessor of symptomatic intracerebral 
hemorrhage (ICH), with the assumption that they may precede following traumatic stroke 
[18, 23]. This view hypothesizes that CMBs are already present at one’s midlife and then 
slowly progress into a symptomatic ICH. Considering that hypertension develops over an 
asymptomatic period of decades, early detection of CMBs joined with clinically 
preventive care on both hypertensive and amyloid angiopathy can reduce the chance of 
traumatic ICH.  In addition to cerebrovascular disease, CMBs also underlie 
neurodegenerative disorders, including AD and subcortical vascular dementia. 
 
3.2.2 Mild cognitive decline 
A faster progression of cognitive decline is found in patients with CMBs [10, 11, 24-27]. 
Cross-sectional analysis of the cognitive consequences of CMBs showed that the 
presence of CMBs is associated with impaired decision-making, decreased attention and 
processing speed, and decline of global cognition [13]. In a meta analysis based on 
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cognitive measurement between patients with and without CMBs, an significant trend of 
poor cognitive function was found (Figure 3.2).  The behavioral severity of CMBs likely 
depends on multiple factors, including location, number, and size of CMBs and the 
presence of other diseases [25, 26]. To measure the distribution and prevalence of CMBs 
for quantitative diagnosis and disease categorization, a scale that includes the presence, 
number, and anatomical distribution called Microbleed Anatomical Rating Scale (MARS) 
is used [16, 27]. Which cognitive functions are perturbed depends mainly on the location 
of the CMBs. Generally, CMBs in deep brain regions, basal ganglia and thalamus, are 
associated with significant cognitive impairment [26]. CMBs found in the temporal lobe 
were associated with memory and attention impairment, whereas those found in the 
frontal lobe impairs memory, attention concept shifting, and psychomotor speed [25].  
 
Figure 3.2 Meta-analysis of cognitive assessment score in CMBs versus non-CMBs. 
(figure from [28] used under Creative Common Attribution 4.0 International (CC BY 
4.0)) 
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The underlying mechanism by which CMBs cause cognitive decline is largely unknown. 
CMBs themselves may have direct effects by disrupting structural or functional 
connectivity of adjacent neurons, or if located at the junction, can reduce cortical–
subcortical connections. In an animal study, microhemorrhages are known to cause a 
persisting local inflammatory response including activation of microglia and perivascular 
macrophages [28]. It is speculated that physical and chemical glial-neuron interaction 
may underlie the cellular basis of cognitive impairments in the neighboring brain region. 
A recent study proposed that multiple CMBs lead to disruption of structural networks in 
the brain [29].  However, studies have so far failed to demonstrate a clear association 
between CMBs and cognitive impairment mainly because the scope of the damage is 
quite limited and often the methodology of measuring cognition is not sensitive enough 
to catch subtle changes.  
 
3.2.3 Subsequent Stroke and Mortality 
A significant association between CMBs and subsequent symptomatic larger stroke is 
predicted in a number of studies. Clinical studies with consecutive brain MRI reveled a 
higher chance of getting ICH in elderly patients [3], and bigger intracerebral bleeding in 
patients with ischemic stroke with CMBs [30, 31]. AD patients with CMBs and patients 
receiving anticoagulants are also prone to cardiovascular events and stroke-associated 
mortality [32, 33]. This traumatic stroke may share similar causation with CMBs. In the 
Rotterdam study, the prospective population based study of the elderly followed up 
patients with CMBs up to 5 years have found strong correlation between mortality and 
non-CAA associated hypertensive CMBs [34]. Therefore, the presence of CMBs can be 
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an important precedent for larger stroke and traumatic cardiovascular diseases. Early 
detection of CMBs and following preventive treatments can therefore become a 
preventive routine of cardiovascular disease and traumatic larger stroke in near future.  
 
3.2.4 Neuropsychiatric Symptoms  
A number of neuropsychiatric symptoms are associated to the presence of CMBs. It is 
known that lobar CMBs are indicators for risk and progression of post-stroke depression 
[35]. Lobar CMBs and subcortical CMBs are associated with developing suicidality and 
fatigue, respectively [36, 37]. CMBs might serve as a pathological mechanism underlying 
emotional liability. Emotional incontinence, such as emotional disinhibition, has been 
found to associate with CMBs [38]. Behavioral and emotional disinhibition is also 
commonly found in patients with AD and its severity increases as the disease progresses 
[39]. Since CAA is a phenotype of AD, CMBs and AD may share similar mechanisms. 
These neuropsychiatric symptoms could be due to disorders in neural circuitry, such as 
molecular mechanisms and perturbed neurotransmission [40].  
 
3.3 Pathophysiology 
Although almost all vascular risk factors and other pathophysiological conditions in the 
brain are known to be associated with CMBs, the cellular and molecular mechanism 
underlying how CMBs develop is unknown. Hypertension is the most common risk 
factor of CMBs, but other genetic and environmental factors contribute. Therefore, in this 
part of the chapter, age-related degeneration of vascular components and functional 
maladaptation to blood flow maintenance is reviewed.  
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3.3.1 Molecular and Cellular Determinants  
Alteration in the extracellular matrix of various tissues that make up vessels in the brain 
can lead to CMBs. The tensile strength of the vascular wall is greatly determined by 
collagen and elastin deposited around smooth muscle cells. Collagen fibers in cerebral 
arterioles are known to prevent damage to the elastic components of the vascular wall.  
Therefore, degenerative or inflammatory changes affecting walls of small arterioles cause 
structural weakening and eventually rupture of the vascular wall. Disruption of the 
extracellular matrix is also a well-understood factor in developing CMBs. Significant 
elastin degradation is found in CAA patients. Patients with genetic disorders affecting 
components of the extracellular matrix often present with micro to macro scale 
intracerebral hemorrhages [41]. One widely used research animal model of intracerebral 
hemorrhage uses the injection of extracellular matrix-degrading enzymes such as elastase 
and collagenases into the brain tissue [42]. 
 
In response to hypertension, vascular smooth muscle cells sense the increase in wall 
tensile stress. In healthy young organisms, smooth muscle cells attenuate mechanical 
stress within the vascular wall and reduce susceptibility for rupture. However, under 
pathological conditions or in aging, this mechanical adaptation processes does not 
function appropriately and intracerebral hemorrhages/CMBs occur. Smooth muscle cell 
loss is common in vessels affected by CAA [43] and decreased cross sectional area of 
smooth muscle cell is found in cerebral arterioles of elderly [44]. Smooth muscle atrophy 
in cerebral arterioles increases susceptibility for vessel rupture. Histological findings 
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from both human patients affected by CADASIL and animal models of CADASIL 
suggest the primary pathology is related to CMBs is the gradual degeneration of smooth 
muscle cells and consequential structure weakening of cerebral vessel [45, 46]. 
  
3.3.2 Increased pulse pressure on the brain microvasculature 
The Windkessel effect refers to the shape of the arterial blood pressure waveform formed 
by the interrelation of the cardiac stroke volume and the compliance of the aorta and 
large elastic arteries. It involves an elastic reservoir in large arteries caused by mismatch 
of blood flow between large cardiac output and relatively smaller volume of blood 
leaving arteries due to the peripheral resistance. Arteries that display the Windkessel 
effect store blood during systole and constantly discharge during both systole and diastole. 
The fluctuation of blood pressure throughout cardiac cycle thus can be dampened and 
allow consistent perfusion to other organs in the body. Myogenic responses in healthy 
individuals involve powerful constraint against cardiac pressure in small cerebral arteries 
that significantly increases hydrodynamic resistance. Due to a large pressure drop along 
the resistance arteries, transmission of transient or chronic surges in pulsatile pressure is 
prevented from reaching the distal brain microcirculation. Both age-related process and 
exposure to vascular risk factors in the elderly increase aortic stiffness. Aortic 
Windkessel compliance is often impaired, and pulsatile systolic pressure transients travel 
without substantial attenuation within the cerebral circulation and reach the vulnerable 
portion of the microvasculature, exacerbating microvascular damage [47]. Microvascular 
injury in the brain has been hypothesized to result from increased pulsatile pressure 
having adverse effect on thinned aging microvasculature [5, 48]. Clinical and 
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experimental evidence suggests that the presence of pulsatile blood flow in elderly 
population leads to pressure-induced microvascular injuries [47, 49, 50]. Taken together, 
age-related autoregulatory dysfunction can be an important contributing factor to the 
pathogenesis of CMBs, and other microvascular injury that lead to blood brain barrier 
disruption, neuroinflammation, and white matter disease. 
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CHAPTER FOUR 
 
CEREBRAL MICROHEMORRHAGES INDUCE A FOCAL, YET DIVERSIFIED 
INFLAMMATORY RESPONSE INCLUDING A COORDINATED PATTERN OF 
MICROGLIAL MIGRATION AND PROLIFERATION  
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4.1 Abstract 
Due to advances in clinical imaging modalities, such as MRI, that enable the detection of 
cerebral microbleeds, the prevalence and impact of these lesions in the aging population 
has received increased emphasis. The presence of cerebral microbleeds is thought to 
gradually impair neuronal function and cause cognitive decline. Previous studies suggest 
that the reaction of inflammatory cells may play an important role in the physiological 
and cognitive impacts of cerebral microbleeds. However, due to its miniscule size and 
asymptomatic nature, on time detection and follow-up study of these small hemorrhages 
were impossible. Here, using extensive in vivo imaging through a cranial window 
implanted on adult mouse brain to follow up on the inflammatory responses after a 
femtosecond laser-induced cortical microhemorrhage, we found a diverse inflammatory 
responses including blood born leukocytes, brain resident microglia and astrocyte. We 
found that blood-borne leukocytes of different phenotypes invade over two weeks. We 
also found a concerted spatiotemporal pattern of microglia migration and proliferation 
near the injury. Proliferation was observed primarily in regions where migration 
decreased microglia density, suggesting that microglia sparsity can trigger focal 
proliferation. Albeit the small size, brain responds with a package of acute inflammatory 
responses to rearrange brain microenvironment that span up to two weeks.   
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4.2 Introduction 
Compared to traumatic intracerebral hemorrhage cerebral microbleeds (CMBs) are 
common and occur at increasing frequency with age, hypertension, cerebral amyloid 
angiopathy, and with genetic conditions such as CADASIL [1]. CMBs vary in size from 
tens of micrometers to several millimeters, and while they are not associated with acute 
neurological symptoms there is growing evidence linking them to accelerated cognitive 
decline and to increased risk for dementia [1-3]. The cellular mechanisms by which 
CMBs affect the health and function of cells in the brain microenvironment remains 
poorly understood. We used a laser-based approach to induce CMBs from targeted 
arterioles in the cortical vasculature of mice. When targeting ~20-µm diameter 
penetrating arterioles, a reproducible ~150-µm diameter CMBs can be produced in the 
cortex [4-6] (Figure 4.1), comparable to the size of the smaller bleeds found in humans 
[7]. Using this model, we have previously reported that microhemorrhages do not lead to 
nearby cell death or degeneration of dendritic arbors [5], or to long-term loss of neural 
responsivity [6]. We did observe an increase in the density of inflammatory cells near the 
lesion, although the classes of cells involved and their origin were not determined [5]. 
Such inflammation could contribute to the cognitive decline associated with CMBs. Here, 
we use in vivo imaging to provide a comprehensive picture of the inflammatory response 
after a microhemorrhage, identifying the cell types involved, their spatiotemporal 
dynamics, and the mechanisms leading to increased inflammatory cell density near the 
lesion. 
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4.3 Results 
To produce CMBs, we used a laser-based approach to rupture targeted penetrating 
arterioles, vessels that branch from the surface arteriole network and dive into the brain to 
feed capillary beds [6]. We irradiated the edge of the vessel lumen with short bursts of 
tightly-focused femtosecond laser pulses with sufficient energy to cause ionization of the 
material at the laser focus, causing the vessel wall to rupture and creating a hematoma of 
up to 150 µm in diameter (Figure 4.1). This laser irradiation deposited relatively little 
total energy, so there was minimal collateral damage to surrounding tissue from the laser 
itself. The ruptured wall of the targeted vessel clotted over a few seconds and restricted 
the size of the hematoma [5]. Blood flow in the targeted penetrating was not disrupted, so 
there is no ischemic injury in this model [4]. This model allows us to control the time and 
location of a CMB in the cortex, allowing the use of in vivo imaging to follow the cellular 
response to the injury. Here, we aim to identify the cellular players associated with the 
inflammatory response to a CMB. We used transgenic mouse lines and bone marrow 
transplant (BMT) chimeras to label different classes of inflammatory cells and study their 
role in the inflammatory response. 
We first examined the role of blood-borne monocytes that invade the tissue after the 
injury. In wild-type mouse receiving bone marrow from Cx3cr1GFP/+  mouse (Cx3cr1GFP/+ 
→ wild-type mice), primarily patrolling monocytes were labeled. We observed the 
infiltration of a small number of green fluorescent protein (GFP) positive cells over days 
to weeks after the lesion (Figure 4.2A top panel), which were nearly all in perivascular 
locations. In mice with inflammatory monocytes labeled with red fluorescent protein 
(RFP) (Ccr2RFP/+), we observed the infiltration of a few labeled cells over a few days  
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Figure 4.1 Femtosecond laser-induced cortical microhemorrhages (A) In vivo two-
photon excited fluorescence images of fluorescently-labeled blood plasma (magenta, i.v. 
injected Texas Red dextran) during creation of a microhemorrhage by ablation of a 
cortical penetrating arteriole. (B) 3D reconstruction of the vasculature and extravagated 
plasma before and after the lesion.  
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after the lesion (Figure 4.2A middle panel), divided about equally between parenchymal 
and perivascular locations (Figure 4.2B). Finally, we imaged mice with all leukocytes 
labeled (UBC-GFP → wild-type), and, again, observed the infiltration of a small number 
of labeled cells (Figure 4.2A bottom panel), divided about equally between parenchymal 
and perivascular locations (Figure 4.2B). Small, punctate, autofluorescent spots also 
appeared over days after the lesion. To get away from irradiation triggered BBB damage, 
all irradiation for BMT were done with lead head shield that resulted in partial chimerism, 
which can represent a portion of cell of interest (All mice used in this experiment had 
more than 63% of bone marrow replaced). Taken together, these data suggest that a 
modest invasion of blood-borne cells occurs after a CMB, consisting of inflammatory 
monocytes (i.e. Ccr2+) earlier and later patrolling monocytes (i.e. Cx3cr1+). While there 
are only a few invading cells, the time course of the invasion of inflammatory and 
patrolling monocytes is similar to that seen after larger ischemic lesions, where blood-
borne cells play a larger role [8].  
 
We next determined the role of brain-resident microglia. As a kind of resident brain 
macrophage, microglia are the first cell type to respond to an inflammatory trigger in the 
central nervous system. Microglia are well known for their ability to surveil adjacent 
tissue by constantly extending and retracting their processes [9]. Without an injury, we 
saw no significant change in microglia location over weeks, although the spatial pattern 
made by their processes changed significantly (Supplementary fig. 4.1). However, in the 
presence of microhemorrhage, microglia extended processes toward the 
microhemorrhage within minutes (Supplementary fig. 4.1). In Cx3cr1GFP/+ mice receiving  
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Figure 4.2 Invasion of a small number of blood-borne inflammatory cells (A) Axial 
projections image stacks showing the response of different genetically-labeled 
inflammatory cell types over 2 weeks after a microhemorrhage. In wild-type animals 
receiving a Cx3cr1GFP/+ bone marrow transplant (Cx3cr1GFP/+ → wild-type), labeled cells 
are patrolling monocytes (top panel, green, GFP). In CCR2RFP/+ animals labeled cells are 
inflammatory monocytes (middle panel, red, RFP; blue, i.v. injected Cascade Blue 
dextran). In UBC → wild-type animals all circulating cells other than red blood cells are 
labeled (bottom panel, green, GFP). Location of insets (on right) are indicated with white 
boxes. (B) Number of cells within the image volume (230 X 230 X 40 µm, centered on 
microhemorrhage) over time for the same genetically-labeled cell populations show in A 
(left). The same data was broken down by cell location perivascular (defined as the cell 
touching the outside of the vessel; middle) and parenchymal (right) locations.  
(Cx3cr1GFP/+ → wild-type: n=12 in 4; CCR2RFP/+: n=6 in 3; UBC → wild-type: n=7 in 2). 
All scale bars are 100 µm, except for the insets in (A), which are 25 µm. Error bars 
indicate SD.   
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Figure 4.3 Local increase in microglia density was due to migration of nearby 
microglia toward the injury In Cx3cr1GFP/+ animals receiving a wild-type bone marrow 
transplant (wild-type → Cx3cr1GFP/+), labeled cells are nearly all microglia (green, GFP). 
Axial projections of two-photon image stacks showing the response microglia over 2 
weeks after a microhemorrhage. (magenta, i.v. injected Texas Red dextran; green, GFP) 
(B) Plot of normalized density of microglia over time after a microhemorrhage for 
regions at different distance from the lesion (wild-type → Cx3cr1GFP/+: n=5 hemorrhages 
from 3 mice). (C) Axial projections of 40-µm thick two photon image stacks over time 
after a microhemorrhage in a Cx3cr1GFP/+ mouse. (D) Migration paths of the microglia 
from panel (C). The color of the segment indicates the time span when that migration 
occurred. The three bold paths correspond to the three cells identified with orange arrows 
in (C). (E) Cumulative radial migration distance between each time point toward the 
microhemorrhage for microglia with different initial distances from the target vessel (n=4 
hemorrhages from 3 mice). All scale bars are 100 µm.  
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BMT from wild-type mice (wild-type →  Cx3cr1GFP/+) microglia were GFP labeled (as 
well as a fraction of patrolling monocytes due to incomplete chimerism). The density of 
GFP-labeled cells near the bleed increased over the first two days (Figure 4.3A). There 
was a trend toward decreased density of labeled cells at distances of 100-200 µm away 
from the injury at 1 day, which recovered by 2 days (Figure 4.3B). Microglia density near 
the lesion site then decreased over two weeks, with microglia regaining a more ramified 
morphology. We then determined the relative role of migration and proliferation in the 
microglia density increase near the microhemorrhage. We followed the movement of 
individual microglia over 48 hr after the lesion in Cx3cr1GFP/+ mice (Figure 4.3C, D). 
Microglia migrated radially inward toward the lesion, with some cells traveling distances 
of up to 40 µm (Figure 4.3D). Microglia within 100 µm of the target vessel began to 
migrate within hours, while cells initially further from the lesion took progressively 
longer to begin migrating (Figure 4.3D). Migration speeds ranged from 0.5 – 2 µm/hour. 
In microglia that migrated, we observed a stereotypical temporal sequence where the cell 
first extended processes toward the lesion, then these processes became thicker, and 
finally the cell migrated along the path of the thickened process toward the lesion 
(Supplementary fig. 4.1). We also observed proliferation of some microglia using time-
lapse 2PEF imaging at times 24 hours or later after the injury (Figure 4.4A, 
Supplementary fig. 4.2). To quantify the role of proliferation in the microglia density 
increase, we used 5-ethynyl-2’-deoxyuridine (EdU) labeling and immunohistology 
approaches (Figure 4.4B-D, Supplementary fig. 4.3). Interestingly, we found microglia 
proliferated predominantly in a ~100-µm wide shell with a ~175-µm radius that  
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Figure 4.4 Proliferation of microglia was observed in a shell surrounding the lesion 
(A) Axial projections of 40-µm thick 2PEF image stacks over time after a 
microhemorrhage in a Cx3cr1GFP/+ mouse. Colored circles indicate cells that will 
proliferate by the next time point. Arrows with matching colors indicate the pair of 
daughter cells. Scale bar is 100 µm. The full time series of this particular hemorrhage is 
shown in Supplementary figure 2. (B) Images of a coronal histological section that 
intersected a microhemorrhage from an animal sacrificed two days after the lesion and 
with repeated EdU injections. Cells that proliferated over those two days are labeled with 
EdU (white), while microglia are labeled with GFP (green). The white box in the left 
image indicates the region for the magnified images to the right. (C) Composite map of 
the location of all microglia and EdU+ microglia from coronal sections across 17 
hemorrhages from three mice, with the location of the microhemorrhage centers aligned 
at (0,0). The cortical surface is at the top of the image. (D) The probability of microglia 
being EDU positive as a function of radial distance from the microhemorrhage from the 
data shown in (g) and a polynomial fit (red trend line). All scale bars are 100 µm. 
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surrounded the targeted penetrating arteriole (Figure 4.4C, D). Taken together, these data 
suggest that microglia near a microhemorrhage respond by rapidly migrating toward the 
injury, leading to a slight decrease in density in the surrounding neighborhood. After a 
day, microglia then proliferate in this region where the density had decreased. This 
pattern of migration and proliferation leads to increased density near the lesion while 
preserving microglia density farther away. After two days, the microglia density close to 
the injury began to slowly decline and neared baseline density by 2 weeks.  
 
The spatial overlap between the regions of microglia density decrease and of microglia 
proliferation suggests that microglia may be triggered to proliferate when their local 
density decreases. To explore this idea, we computationally simulated the response of 
microglia to a microhemorrhage (Figure 4.5A). First, we used our experimental 
measurements to extract probability distributions for microglia migration distance 
(Supplementary figs. 4.4 and 4.5) and microglia proliferation (Figure 4.4D), each as a 
function of distance from and time after the microhemorrhage. The resulting simulations 
showed an increase in microglia density near the lesion over 48 hr that agreed with in 
vivo data, validating this simulation approach (Figure 4.5B). A surrounding shell-shaped 
region with a slightly decreased microglia density at 24 hr was also evident and filled in 
due to proliferation by 48 hr (Figure 4.5B). To test the idea that microglia proliferation 
depended on changes in the local microglia density, we next ran the simulation using 
experimentally measured microglia migration but now assuming that microglia were 
triggered to proliferate if their domain volume increased by more than a defined factor 
(Figure 4.5C and Supplementary fig. 4.6). We found that the simulation predicted the  
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Figure 4.5 Simulation of microglia density changes due to migration and 
proliferation after a microhemorrhage (A) Map of the density of microglia including 
only migration and not proliferation in the simulation (top), of microglia committed to 
division (middle), and of total microglia density (bottom) at baseline and at 24 and 48 hrs 
after the microhemorrhage. (B) Plot of normalized density of microglia as a function of 
distance from a microhemorrhage at 24 (top) and 48 (middle) hrs after the injury for the 
simulation showing the density including migration and proliferation (blue) or just 
migration (green). The lower plot shows in vivo measurements at 24 (red) and 48 (black) 
hrs after the lesion (same data as shown in Figure 3B; n=5 hemorrhages from 3 mice). 
Lines (shading) indicate mean (SD). (C) Map of the total density of microglia (left) and 
of the density of microglia committed to division (right) at 48 hrs after a 
microhemorrhage using models where microglia proliferation occurs when the domain 
volume of a microglia increases by more than 50% percentage. (D) The fraction of 
microglia that have either committed to divide or are daughter cells of a proliferation 
event as a function of distance from and at 48 hrs after the microhemorrhage for different 
density-dependent microglia proliferation models. The dashed line represents the fraction 
of microglia that were found to be EdU positive in experiments (same data as in Fig. 4D). 
Scale bars are 200 µm. 
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observed spatial distribution of microglia proliferation using a 50% volume increase as 
the threshold value to trigger a proliferative event (Figure 4.5D).  
 
We also sought to understand the participation of astrocytes in the inflammatory response 
following a CMB. Astrocytes are another subtype of glia cell having numerous functions  
including guiding neuronal development and synapse formation, facilitating proper 
propagation of action potentials, and acting as one of the gate keepers of the brain by 
being part of the brain blood barrier (BBB). Coordination between microglia and 
astrocytes seems required for fine-tuned regulation and resolution of inflammatory 
responses [10]. Although the representation of astrocyte reactivity by the expression level 
of glial!fibrillary!acidic!protein (GFAP) is still debatable, this approach is widely used. 
After creating laser-induced microhemorrhages in Cx3cr1GFP/+ mice, we sacrificed mice 
at different time points and immune-stained for GFAP. We saw extensive expression of 
GFAP around the lesion starting two days and peaking at seven days after the injury 
(Figure 4.6A). Over time, GFAP expression declined and an astrocytic glial scar was not 
found near the lesion at later time points (Figure 4.6B).  
 
4.4 Discussion 
Although CMBs do not elicit noticeable symptoms, increasing evidence suggests that 
CMBs are not clinically silent. CMBs are common in the elderly population and are more 
prevalent in patients with cardiovascular risk factors, such as hypertension. The presence 
of CMBs is highly correlated with cognitive impairment and functional decline. 
However, the underlying mechanism by which CMBs cause cognitive decline is largely  
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Figure 4.6 Dense appearance of astrocytes near the hemorrhage (A) Images of 
coronal histological section that intersected a microhemorrhage from animals sacrificed 
two, seven, fourteen, and twenty one days after the lesion. Microglia are visualized by the 
expression of CX3CR1-GFP (top panels), astrocytes are visualized by immunolabeling of 
GFAP (middle panels). The bottom panels show and overlay. (B) The number of image 
pixels above a threshold as a function of distance distance away from the lesion and over 
time for microglia and astrocytes. Scale bars are 100µm. 
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unknown. To understand how the brain responds to such small bleeds, we used a series of 
in vivo imaging to follow the behavior of a number of different cell types after the injury. 
In previous studies, we found that these bleeds to not cause the death of nearby neurons 
nor the degeneration of their dendritic arbors. We also found that while neurons near the 
injury initially fired fewer action potentials in response to a stimulus, they recovered 
within hours. In this work, we detail the cellular players in the inflammatory response we 
observe after the injury. The initial response was dominated by brain-resident microglia, 
which exhibited a coordinated pattern of migration and proliferation that led to an 
increased density of microglia near the lesion (primarily by migration from the 
surrounding tissue), while later recovering the density of microglia in the surrounding 
tissue (by proliferation). A small number of invading leukocytes were also observed, with 
more inflammatory monocytes earlier, followed by patrolling monocytes. Although the 
number of invading monocytes was small, these cells were present near the lesion for 
days, perhaps participating in regulating the inflammatory response with brain resident 
glial cells.  
 
The concept of neuroinflammation implies an inflammatory process originate primarily 
from brain resident glial cells. Glial cells that primarily respond to inflammatory insults 
are microglia, the resident myeloid cells of the brain, as well as astrocytes. Both 
microglia and astrocytes have pro- and anti-inflammatory functions dependent on the 
mode of injury. In response to inflammatory stimuli, microglia take on a phagocytic 
phenotype to clear cellular debris, and secrete cytotoxic factors, cytokines, growth 
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factors, and even neurotransmitters that may influence function in neurons and other cells 
[11]. It is known that Interleukin-1β (IL-1β) levels increase during long term potentiation 
(LTP) and are required for maintenance of long term changes [12]. Increased release of 
IL-1β by microglia in normal conditions can thus have a mild effect on LTP signaling. 
Tumor necrosis factor-α (TNFα), also released by microglia, is involved in synaptic 
plasticity by increasing surface AMPA receptors [13]. Interestingly, mice deficient in 
CX3CR1/CX3CL1 (fractalkine receptor in microglia) are reported to lack LTP and 
hippocampal-dependent learning and memory, suggesting that microglia may play a key 
role in synaptic plasticity [14]. These actions by microglia can either exacerbate damage 
by, for example, promoting excitotoxic injury [15] or inappropriately phagocytosing 
synapses [16], or they may play a protective role by, for example, limiting neuronal 
injury due to ischemia [17]. Thus, activation and redistribution of microglia near a CMB 
likely affects the behavior of nearby neurons and other cells and may contribute to the 
cognitive effects associated with these lesions. The function of astrocytes was long 
thought to be restricted to maintaining and supporting the health and function of neurons. 
However, it is now widely understood that astrocytes actively respond in an array of CNS 
diseases, just like microglia. Recently, it has been found that microglia activation induces 
A1 reactive astrocyte by releasing three cytokines: Interleukin 1 alpha (IL-1α), TNFα, 
and the complement component subunit 1q (C1q) [18]. Reactive astrocytes can be more 
harmful than protective to the adjacent neuronal population. Altogether, coordinated 
activation of microglia and astrocyte can change the strength of synaptic connectivity, 
affect synapse formation, and participate in maturation and elimination of neuronal 
spines, all of which are the fundamental basis of neuronal plasticity.  
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In the healthy brain, microglia are intercalated! throughout! the entire parenchyma and 
are arranged in non-overlapping domains, which they surveil by extending and retracting 
processes [9]. Through this surveillance, microglia can detect subtle changes in the 
microenvironment and react to any kind of insult, sensed with an array of surface 
receptors including purigenic [19] and fractalkine [20] receptors, as well as receptors for 
complement fragments [21], immunoglobulin, and adhesion molecules [22]. Like other 
tissue-resident macrophages, microglia maintain their population locally by proliferative 
self-renewal [23-26], with sporadic proliferation under normal conditions and clonal 
expansion under pathological conditions [26]. Here, through a series of in vivo analyses, 
we describe the concerted spatiotemporal response of microglial migration and 
proliferation in a focal injury model. We observed proliferation of microglia 
predominantly in regions where the density of microglia declined due to migration, 
suggesting that microglia sense their local density and proliferate when the density 
decreases. It is not clear how microglia sense such changes in density, but it has been 
reported that microglial processes repel one another when they make contact [9]. This 
coordinated pattern of migration and proliferation can thus explain how microglia 
maintain their characteristic organization in non-overlapping domains after a nearby focal 
injury. 
 
Here in this work, a single event of bleeding from a penetrating arteriole induced a series 
of microglia and later astrocyte activation as well as invasion of monocytes of different 
phenotype that spans more than a week. Although this small bleed does not cause direct 
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neuronal degeneration [5] nor loss of responsiveness to external stimuli [6], this 
prolonged inflammatory response could cause subtle modulation of normal brain 
function, and the accumulation of such events could in later life, underlie cognitive 
decline.  
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Supplementary figure 4.1 Microglia locations were highly stable in the absence of an 
injury but immediately responded to a microhemorrhage and migrateed toward the 
injury following a path defined by previous processes extension (A) Axial projections 
of 50-µm thick 2PEF image stacks over time in a  Cx3cr1GFP/+ mouse taken ~100 µm 
beneath the cortical surface on the contralateral side of the brain from the location of any 
microhemorrhage (magenta, i.v. injected Texas Red dextran; green, GFP; red, YFP 
expressed in Layer V pyramidal neurons). Although the microglial processes differed in 
spatial arrangement between time points, nearly all microglia in the imaging field 
retained their approximate position. Scale bar is 50 µm. (B) Axial projections of 40-µm 
thick 2PEF image stacks over time after a microhemorrhage in a Cx3cr1GFP/+ mouse 
(magenta, i.v. injected Texas Red dextran; green, GFP). The grey-scale images show just 
the GFP-labeled microglia for the last four time points. For several cells, the solid colored 
traces identify major branches of processes that have extended toward the 
microhemorrhage. At subsequent time points, these cells (position over time indicated by 
circles with matching color) migrated along the path defined by the extended process. 
The path the cell migrated along is indicated with dashed lines of matching color. The 
yellow circles indicate nearby microglia that migrated into the region of interest, either 
from above or below this region or from the sides. Scale bar is 100 µm. 
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Supplementary figure 4.2 Daughter cells from a microglia proliferation event were 
observed only more than 40 hours after a microhemorrhage (A) Axial projections of 
40-µm thick 2PEF image stacks over time after a microhemorrhage in a Cx3cr1GFP/+ 
mouse (magenta, i.v. injected Texas Red dextran; green, GFP; red, YFP expressed under 
control of the Thy1 promoter to label Layer V pyramidal neurons and their axons and 
dendritic arbors, which were visible at this depth). Greyscale images show just GFP-
labeled microglia. Colored circles indicate cells that will proliferate by the next time 
point. Arrows with matching colors indicate the pair of daughter cells. Scale bar is 100 
µm. (B) Three-dimensional reconstructions of some of the microglia cell division events 
shown in (A). Colored circles and arrows indicate corresponding cells from (A). Scale 
bars are 10 µm. 
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Supplementary figure 4.3 Microglia proliferation was observed in the region 
surrounding a microhemorrhage Histology images showing GFP-labeled microglia, 
DAPI labeled nuclei, EdU positive cells (EdU injected every eight hours for two days 
after microhemorrhage induction), and Ki67 expression (imunolabeled). (A) Section that 
intersects a microhemorrhage. The arrow indicates a cell that was labeled with EdU, 
Ki67, and GFP, indicating a microglia that was actively proliferating. (B) Negative 
control region from contralateral cortex. (C) Positive control region from sub-ventricular 
zone. Scale bars in a and b are 100 µm, in c it is 50 µm.  
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Supplementary figure 4.4 Microglia migration distance as a function of distance 
from the targeted arteriole and time after the injury (A) Example of one simulation 
showing coordinates of microglia at two days after the microhemorrhage and the 
migration traces of individual microglia. Microglia committed to division and those 
newly generated are also indicated. (B) Red dots indicate experimental measurements of 
microglia migration from in vivo imaging (e.g. Figure 4.3 C-E). The average migration 
distance from this same data is shown in Figure 4.3E. The color map shows the 
probability distribution of migration distance for a microglia at a given distance from, and 
time after, the microhemorrhage. This probability distribution was derived from the 
experimental data by calculating the density of points over a sliding window that was 5 
µm high (migration distance) and 20 µm wide (distance from targeted arteriole) and then 
smoothing. This probability function was then used for the simulations shown in Figure 
4.5. 
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Supplementary figure 4.5 Distance to nearest neighboring microglia as a function of 
distance from the targeted arteriole and time after the injury Blue dots indicate 
experimental measurements of microglia nearest neighbor distances from the same data 
set used in Supplementary fig. 4.4 and Figure 4.3. Red line represents the mean, while the 
pink shadow represents ±1 SD from the mean.  
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Supplementary figure 4.6 Calculation of the domain volume for each microglia 
using a topographic watershed algorithm over time after a microhemorrhage When 
microglia migrated toward the injury, the domain volume of some microglia increased. 
(A) Map of the total density of microglia (top) and of the density of microglia committed 
to division (bottom) at 48 hrs after a microhemorrhage using models where microglia 
proliferation occurs when the domain volume of a microglia increases by more than the 
percentage indicated at the top of each column. (B) In this simulation, when the volume 
increased by more than 50% for a microglia, it committed to dividing and created a new 
microglia 8 hr later. Bottom panels show the microglia territories (note the image shows 
just a cross-sectional plane of these volumes) and the color indicates the size of the 
domain volume. Top panels show microglia locations and migration traces. The pink 
(black) circles indicate microglia that have committed to divide (are newly born). The red 
facets in the left panels also indicate these new microglia. The hemorrhage is at the center 
of the frame.  
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4.5 Methods 
4.5.1 Animals Experiments were performed in 20 to 40 week old transgenic mice on a 
C57BL/6J genetic background. Breeders were purchased from The Jackson Laboratory 
(CX3CR1-GFP #8451 [27], UBC-GFP #4353 [28], CCR2-RFP #17586 [29], Thy1-
YFPH #3782 [30], wild-type) and animals were crossed and/or received bone marrow 
transplants to fluorescently label targeted cell types. All animal experiments were 
conducted in strict accordance with the recommendations in the Guide for the Care and 
Use of Laboratory Animals published by National Institutes of Health, and all animal 
procedures were approved by the Cornell University Institutional Animal Care and Use 
Committee (protocol numbers 2009-0043 and 2015-0029). 
 
4.5.2 Bone marrow transplantation and chimerism Bone marrow chimeras were 
generated from transgenic and wild-type mice. Six to eight week old recipient mice were 
anesthesized with ketamine and xylazine (10 mg/100 g mouse weight ketamine; 1 
mg/100 g xylazine; intraperitoneally). Mice were placed in a custom-built lead head 
shield and exposed to a lethal dose of gamma irradiation (10 Gy). Donor mice (2-4 
months old) were deeply anesthetized using isoflurane (~3% in oxygen). Both femurs 
were removed and the animals euthanized by cervical dislocation. Bone marrow cells 
were flushed out from the femur with sterile saline and the density of cells was measured 
using a hemocytometer. Recipient mice received ~107 donor bone marrow cells through 
retro orbital injection 1-3 hr after irradiation. Nine weeks after the bone marrow 
transplant, ~100 µL of blood was collected from submandibular bleeding and the degree 
of chimerism was assessed by flow cytometry. We only used mice in which the 
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percentage of circulating white blood cells that came from the donated bone marrow was 
more than 63%. Although the head shielding we used here reduces the degree of 
chimerism achieved with the bone marrow transplant, it avoids gamma irradiation of the 
head, which could drive brain inflammation that may confound interpretation of the 
results [23, 31]. 
 
4.5.3 Chronic cranial window preparation Optical access to brain was achieved 
through a long-term implanted glass-covered cranial window, as described previously 
[32]. Animals were anesthetized using isoflurane (1.5–2% in oxygen) and placed on a 
feedback controlled heating blanket that maintained body temperature at 37˚C (50-7053P; 
Harvard Apparatus). Mice were given either glycopyrrolate (0.05 mg/100 g mouse 
weight; intramuscularly; Baxter, Inc.) or atropine sulfate (0.005 mg/100 g; 
subcutaneously; 54925-063-10, Med-Pharmex Inc.) to prevent lung secretions. Animals 
were also given dexamethasone (0.025 mg/100 g; subcutaneously; 07-808-8194, Phoenix 
Pharm Inc.) and ketoprofen (0.5 mg/100 g; subcutaneously; Zoetis Inc.) to reduce post-
surgical inflammation and pain. A 6-mm diameter bilateral craniotomy was performed 
over parietal cortex using a dental drill. The exposed brain was covered with sterile saline 
and sealed with an 8-mm diameter glass coverslip using cyanoacrylate glue (Loctite 495; 
Henkel), tissue adhesive (70200742529, 3MTM), and dental cement (Co-Oral-Ite Dental 
Mfg Co.). Animals were given a single injection of 5% weight/volume (w/v) glucose in 
saline at the conclusion of surgery (1 ml/100 g). All mice recovered at least 14 days from 
this surgery before in vivo imaging and microhemorrhage induction. 
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4.5.4 Multi channel in vivo two-photon excited fluorescence microscopy Mice were 
anesthetized with isofluorane (1.5–2% in oxygen) and placed in a stereotaxic apparatus 
equipped with a feedback-controlled heating pad. As above, mice were given either 
glycopyrrolate (0.05 mg/100 g; intramuscularly) or atropine sulfate (0.005 mg/100 g; 
subcutaneously) to prevent lung secretions. The blood plasma was labeled with either red 
or blue fluorescent dextran-conjugated dyes (2.5% w/v Texas-Red 70 kDa used with GFP 
positive cells, D-1830; 5% w/v Cascade-Blue 10 kDa used with RFP positive cells, D-
1976; Invitrogen) diluted in sterile saline and retro-orbitally injected (50 µl) before 
imaging. Imaging was performed on a custom-built four-channel 2PEF microscope using 
the following emission filters (center wavelength/bandwidth): 417/60 (Cascade-Blue), 
494/41 (GFP), 550/49 (YFP) and 641/75 nm (RFP and Texas-Red) separated with long-
pass dichroics with cutoffs at 458, 520 and 562 nm. Excitation pulses came from a 
tunable Ti:Sapphire laser (Vision II, Coherent) set to a wavelength of 880 nm for imaging 
YFP, GFP, Texas-Red and to 800 nm for Cascade-Blue. An additional femtosecond laser 
at 1045 nm was used to image RFP (Yg fiber oscillator/amplifier; Satsuma; Amplitude 
Système). Image stacks were acquired through ScanImage software (version 3.8, Vidrio 
Technologies)[33]. Respiration was monitored throughout the imaging session and the 
isoflurane level was adjusted to maintain a steady breathing rate of ~1 Hz. During the 
imaging session, mice received an hourly dose of 5% w/v glucose in saline (1 ml/100 g). 
In animals that received atropine and not glycopyrrolate, the atropine was supplemented 
hourly (0.001 mg/100 g; subcutaneously). 
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4.5.5. Induction of microhemorrhage by femtosecond laser ablation 
Microhemorrhages were produced in the descending segment of penetrating arterioles 
(PAs) as previously described [4-6]. Femtosecond laser pulses were tightly focused (20x, 
1.0 numerical aperture (NA), water immersion, cover glass corrected objective; W Plan-
Apochromat (Zeiss)) on the outer edge of the vessel lumen of the targeted PA. We used 
50-fs duration laser pulses produced by a Ti:sapphire regenerative amplifier (Legend 1 k 
USP; Coherent), pumped by a Q-switched laser (Evolution 15; Coherent) and seeded by a 
Ti:Sapphire oscillator (Chinhook; Kapteyn-Murnane Laboratories Inc.) that was pumped 
by a continuous wave laser (Verdi-V6; Coherent, Inc). Laser energy was controlled using 
neutral density filters. We began with a laser energy of ~50 nJ and targeted the PA about 
100 µm beneath the cortical surface. A burst of 100 laser pulses (1 kHz repetition rate) 
was applied while we watched for extravasation of fluorescently-labeled blood plasma 
from the targeted vessel. If the vessel did not rupture then a burst of 200 and then 300 
pulses with the same energy was applied. If the vessel still did not rupture, the laser pulse 
energy was increased by 50% and this process was repeated. This procedure ensured that 
the minimum laser energy required to rupture the targeted vessel was used to induce a 
microhemorrhage. Typical laser energies used to rupture PAs varied from 95 to 240 nJ, 
largely dependent on the depth at which the vessel was targeted. We acquired 2PEF 
image stacks with 1 µm axial spacing before and after inducing the hemorrhage, as well 
as movies of the hemorrhage induction process. 
 
4.5.6 Analysis of microglia density after a microhemorrhage Microglia density was 
assessed using mice with microglia labeled with GFP and a reduced number of patrolling 
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monocytes labeled with GFP (Cx3cr1GFP/+ with wild-type bone marrow). We imaged 
before and repeatedly over two weeks after the microhemorrhage. At each time point, 
multiple image stacks were taken at different distances from the microhemorrhage (center 
of imaging field at 0, 100, 300 µm away) and from a control region at least 1 mm away 
from any microhemorrhage. In each mouse, we made one or two microhemorrhages and 
imaged one control region. We manually identified the location of the cell body for each 
microglia in a 40-µm thick slab, centered at the depth of the microhemorrhage, across 
these imaging times and locations. As a means to assess the acute microglia response to 
the injury, we also categorized microglia as polarized if more than 50% of their processes 
were directed, within a 30-degree cone, toward the center of the microhemorrhage. 
 
4.5.7 Counting infiltration of blood-derived inflammatory cells We used transgenic 
and bone-marrow transplanted mice to label specific circulating inflammatory cell 
populations, as described above. Because infiltrating inflammatory cells tended to stay 
close to the target vessel, we imaged just one location, centered on the lesion, over time. 
In addition to determining the location of each infiltrating cell, we further classed them as 
being perivascular if they surrounded or made contact with the target vessel and as being 
parenchymal if they did not.  
 
4.5.8 Time lapse imaging for assessing microglia migration speed and proliferation 
To monitor the speed of microglia migration, we took 2PEF image stacks in Cx3cr1GFP/+ 
or in Cx3cr1GFP/+Thy1-YFP mice at the microhemorrhage site every four hours for 16 
hours and then every eight hours up to 48 hours after the lesion. Animals were woken up 
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between each subsequent imaging session. The first imaging session took about two 
hours and involved baseline imaging, producing the microhemorrhage, and taking post-
injury images. In subsequent imaging sessions, animals were anesthetized for ~20 min. 
while the same region was imaged. At these subsequent imaging sessions, animals were 
supplemented with additional dose of 5% w/v glucose in saline (1 mL/100 g) and of 
atropine (0.001 mg/100 g; subcutaneously), as well as with half the volume of fluorescent 
dextran dye (2.5% w/v Texas-Red; D-1830, Invitrogen) diluted in sterile saline and 
injected retro-orbitally (25 µl). We used the Rigid Registration plugin in FIJI to align all 
image stacks, using blood vessels and/or dendritic arbors (in animals with Thy1-YFP) as 
alignment guides. Because not all microglia migrated and because those that did tended 
to not migrate very far (<25 µm) between time points, it was possible to identify each 
individual microglia across each imaging time point to determine their migration paths. 
We also observed microglia proliferation, characterized by an elongated cell body shape 
and then two daughter cells at that location in the next imaging session (and with all 
neighboring microglia accounted for).  
 
4.5.9 Assessment of microglia proliferation using post-mortem histology To assess 
microglia proliferation, we placed microhemorrhages in mice as described above and 
then gave intraperitoneal injections of 5-ethynyl-2’-deoxyuridine (EdU; 2 mg/100 g) 
every 8 hr for two days. After the 6th injection, mice were sacrificed for histological 
analysis. Animals were transcardially perfused with 15 ml of phosphate buffered saline 
(PBS) (Sigma-Aldrich) followed by 30 ml of 4% w/v paraformaldehyde (PFA) (Fischer 
Scientific) in PBS. Brains were extracted, stored overnight in in 4% PFA in PBS at 4°C, 
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then in 15% w/v sucrose in PBS for 8 hr at 4°C, followed by 24 hr in 30% sucrose, and 
then in 60% sucrose until sectioning. We used a fiducial marking procedure to 
unambiguously identify individual microhemorrhages in the tissue sections. Briefly, 
fiducial marks were made just lateral to the edges of the craniotomy by insertion of a 30-
gauge needle. Brains were then briefly immersed in a dilute solution of Toluidine Blue, 
which labeled mast cells on the brain surface and enabled us to visualize the large surface 
blood vessels as well as the fiducial marks. The microhemorrhage locations were known 
relative to the large surface vessels from 2PEF images and the Toluidine Blue stained 
image allowed us to define the location of the fiducials relative to the large surface 
vessels, and therefore the location of the microhemorrhages relative to the fiducials. The 
tissue was then frozen and cut into 20-µm thick coronal sections on a cryostat and 
mounted onto microscope slides. The fiducial marks were found in the series of brain 
sections and used to identify the tissue sections that went through a microhemorrhage. 
We used a kit to detect EdU-labeled cells (Click-iT EdU, C10340, Invitrogen) in the 
tissue sections. In addition, we immunolabeled for expression of Ki67, a protein 
expressed during active cell proliferation, using a rabbit anti-Ki67 monoclonal primary 
antibody at 1:100 dilution (GTX16667, GeneTex) with a goat anti-rabbit Alexa flour 594 
conjugated secondary antibody at 1:200 dilution (A-11037, Invitrogen). Stained slides 
were mounted using an anti-fade mounting medium that contained DAPI (Vetashield, H-
1200, Vector Laboratories). Fluorescent images were collected on an inverted confocal 
fluorescence microscope (LSM880, Zeiss) using a 40x/1.1 NA long working distance 
water immersion objective (421767-9971-711, Zeiss). 
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4.5.10 Assessing astrocyte activation using post-mortem histology For astrocyte 
labeling, we scarified Cx3cr1GFP/+ mice at 2, 7, 14, and 21 days after the induction of a 
microhemorrhage and slides with microhemorrhages (identified as above) were stained 
for GFAP using a chicken anti-GFAP polyclonal antibody at 1:1000 dilution (ab4674, 
abcam) with a goat anti-chicken Alexa flour 594 conjugated secondary antibody at 1:200 
dilution (A-11042, Invitrogen). Fluorescence images of microglia (GFP) and astrocytes 
(Alexa flour 594) were collected on the same inverted confocal microscope.  
 
4.5.11 Modeling microglia density change after microhemorrhage We developed a 
simple model of the microglia response to a brain microhemorrhage using our data on 
microglia migration and proliferation. In vivo measurements from 11 Cx3cr1GFP/+ mice 
revealed a microglia density of 1.3±0.3×104 cells/mm3, and a minimum nearest neighbor 
distance between microglia of 37±11 µm. In our simulation, we first seeded microglia at 
random locations in an 800 × 800 × 50 µm volume, while matching this cell density and 
spacing. We used in vivo measurements of microglia migration after the 
microhemorrhage (Figure 4.3C-E) to calculate a probability distribution of the radial 
migration distance for microglia at different distances from and times after the 
microhemorrhage (Supplementary fig. 4.4B; smoothed over 20 µm in distance from the 
lesions and 5 µm in migration distance). This probability distribution was used to 
determine the radial migration of each microglia every 4 hr for 16 hrs and then every 8 hr 
until 48 hr after the lesion. From our in vivo imaging, we also quantified the minimum 
nearest-neighbor microglia spacing as a function of distance from and time after the 
lesion (Supplementary fig. 4.5; smoothed over 20 µm in distance from the lesions and 5 
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µm in migration distance). If the migration of a microglia placed it closer to another 
microglia than one standard deviation below the mean of this nearest-neighbor microglia 
spacing then we determined a new migration distance for that cell.  
The proliferation probability and the time for microglia cell division was determined 
from the number of EdU and Ki67 positive microglia in the histology images. Only cells 
that were actively in the cell cycle when the animal was sacrificed would express Ki67. 
With the EdU dosing strategy we used, all cells that had entered the cell cycle over the 
full 48 hours after the injury, as well as all daughter cells, would be labeled. The number 
of Ki67, NKi67, and EdU positive cells, NEdU, at a time, T, after the microhemorrhage are 
thus given by: 
 
 
 
 
 
where N is the number of microglia at baseline, τ is the time required for microglia cell 
division, R(r) is the probability of a microglia being triggered to proliferate and is 
dependent on r, the distance from the microhemorrhage, and t is time after the lesion 
given in discrete steps (hrs). This model assumes that within this time frame (maximum 
simulation times of T=48 hrs), the daughter cells of a microglia proliferation event do not 
divide again. We then calculated  and τ to match the spatially dependent fraction of 
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microglia that were EdU positive (Figure 4.4D) and the ratio of Ki67 to EdU positive 
microglia . At each time point in the simulation, we used the 
distance-dependent probability of a microglia entering the cell cycle, R(r), to identify 
cells that will later divide. We then seeded a new microglia at a location ~30 µm away 
after a time, τ. We averaged the results of 1,000 simulations.   
 
4.5.12 Modeling a causal relationship between microglia density change and 
proliferation To examine the hypothesis that microglial proliferation was initiated by a 
density changes, we then used an alternate model for microglia proliferation that 
depended only on local changes in microglia density. After seeding microglia, we 
assigned each image voxel to the closest microglia, thereby defining a domain volume for 
each microglia. We then ran the simulation with microglia migration handled as 
described above. At each time step, we recalculated the domain volume for each 
microglia. If the domain volume increased by more than a specified fraction then that cell 
was flagged to divide and after a time, τ, a new microglia was seeded ~30 µm away.  
 
4.5.13 Image, data, and statistical analysis All 2PEF images were analyzed using FIJI 
[34]. For the generation of images of fluorescent species with overlapping spectral 
profiles, we used a custom linear unmixing code written in Matlab. Image manipulations 
were limited to linear adjustments of image contrast. All displayed images represent 
maximal projections of 2PEF image stacks except for the single plane movie frames in 
Figure 4.1A and the renderings in Figure 4.1A and Supplementary fig. 4.2B, which used 
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Volocity (PerkinElmer Inc) and Imaris (Bitplane), respectively. Data in all plots 
represents the mean and error bars represent the standard deviation. 
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CHAPTER FIVE 
 
LABEL FREE MEASUREMENT OF CORTICAL BLOOD FLOW SPEED IN 
INDIVIDUAL VESSELS USING THIRD HARMONIC GENERATION 
MICROSCOPY 
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5.1 Introduction 
In recent decades, multi-photon excitation fluorescence (MPEF) microscopy has become 
one of the most important imaging tools used in biomedical research by enabling deeper 
imaging in scattering tissue with high resolution and contrast [1-3]. With the 
development of various fluorescent agents combined with advancements in genetic 
engineering, a detectable fluorescent signal can be used to monitor cell structure and 
function in a living animal [4-7]. As a result, the advent of nonlinear microscopy opened 
an era of minimally invasive in vivo imaging to study cellular structures, processes and 
responses to systematic manipulations in their natural state. Furthermore, three photon-
excited fluorescence (3PEF) has increased imaging depth up to 900µm from the cortical 
surface, enabling deep brain imaging [8, 9].  However, both genetic modulation of 
animals for expressing fluorescent proteins and injection of various fluorescent dyes can 
systemically and functionally modify the exact nature of biological phenomena to a 
degree that is not fully understood.   
Harmonic generation is a coherent (phase-preserving) process characteristic of a resonant 
material and requires no actual absorption of laser photons. Therefore, the laser-induced 
harmonic generation (HG) leaves no energy deposition in the impacted material. A 
number of endogenous biological structures possess a structural property that emits 
second harmonic generation (SHG) [10, 11] and third harmonic generation (THG) [12-
15] when its phase matches the phase of the excitation source. Using these endogenous 
structures therefore avoids common issues associated with fluorescence excitation 
microscopy, such as photodamage, phototoxicity, photobleaching, and toxicity from 
fluorescent dyes.  
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The traditional method for measuring blood cell speed in vivo is achieved by labeling 
blood plasma with an intravenous injection of fluorescence-conjugated dextran dyes and 
laser scanning a line along a vessel to create a distance-time image [16-18]. Here, the 
negative signal indicates the presence of a blood cell, which form angled stripes due to 
the temporal displacement of blood cells. The slope of the stripes can then be used to 
calculate blood cell speed. Red blood cells (RBCs) and leukocytes have been shown to 
express high THG signals [19, 20]. Our preliminary observations suggest that the THG 
signal from 1300nm excitation produces greater blood cell contrast compared to 3PEF of 
dextran-conjugated dyes when measuring blood flow speed. Therefore, we demonstrate 
the use of THG microscopy as a label-free live brain-imaging tool to measure cortical 
blood flow speed, and examined the changes to cortical blood flow from exogenous 
contrast agent, fluorescein isothiocyanate (FITC) conjugated dextran dye. 
 
5.2 Materials and Methods 
5.2.1 Animals Experiments were performed in 4 month-old, wild-type mice (C57BL/6J). 
All animal experiments were conducted in strict accordance with the recommendations in 
the Guide for the Care and Use of Laboratory Animals published by National Institutes of 
Health, and all animal procedures were approved by the Cornell University Institutional 
Animal Care and Use Committee (protocol numbers 2009-0043 and 2015-0029). 
 
5.2.2 Chronic cranial window preparation Optical access to the brain was achieved via 
a cranial window using an implanted 8mm glass coverslip, as described previously [21]. 
Animals were anesthetized using isoflurane (1.5–2% in oxygen) and placed on a 
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feedback-controlled heating pad that maintained body temperature at 37˚C (50-7053P; 
Harvard Apparatus). Mice were given atropine sulfate (0.005 mg/100 g; subcutaneously; 
54925-063-10, Med-Pharmex Inc.) to reduce buildup of lung secretions. Animals were 
also given dexamethasone (0.025 mg/100 g; subcutaneously; 07-808-8194, Phoenix 
Pharm Inc.) and ketoprofen (0.5 mg/100 g; subcutaneously; Zoetis Inc.) to reduce post-
surgical inflammation and pain, respectively. A 6-mm diameter bilateral craniotomy was 
performed over parietal cortex using a dental drill. The exposed brain was covered with 
sterile saline and sealed with an 8-mm diameter glass coverslip using cyanoacrylate glue 
(Loctite 495; Henkel), tissue adhesive (70200742529, 3MTM) and dental cement (Co-
Oral-Ite Dental Mfg Co.). Animals were given a single subcutaneous injection of 5% 
weight/volume (w/v) glucose in saline at the conclusion of surgery (1 ml/100 g). 
Following surgery, mice were given at least 21 days to recover before in vivo imaging. 
 
5.2.3 Multi channel in vivo multi-photon excited microscopy Mice were anesthetized 
with isofluorane (1.5–2% in oxygen) and placed in a stereotaxic apparatus equipped with 
a feedback-controlled heating pad. As above, mice were given atropine sulfate (0.005 
mg/100 g; subcutaneously) to reduce buildup of lung secretions. Imaging was performed 
on a custom-built three-channel multiphoton microscope using the following emission 
filters (center wavelength/bandwidth): 417/60nm, 494/41nm, 550/49nm separated by 
long-pass dichroics with cutoffs at 458nm and 520nm. To generate 1300nm laser light to 
induce 3PEF and THG, an optical parametric amplifier (OPA) (Coherent, Opera-F) was 
seeded by a diode-pumped femtosecond laser (60 µJ/pulse at 1 MHz; Coherent, Monaco). 
A tunable Ti:Sapphire laser (Vision II, Coherent), set to a wavelength of 800nm, was 
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used for 2PEF. Image stacks were acquired through ScanImage software (version 3.8, 
Vidrio Technologies) [22]. Respiratory rate was monitored throughout the imaging 
session and the isoflurane level was adjusted to maintain a steady respiratory rate of ~1 
Hz. During the imaging session, mice received an hourly dose of 5% w/v glucose in 
saline (1 ml/100 g; subcutaneously) and atropine (0.001 mg/100 g; subcutaneously).  
 
5.2.4 Repeated imaging with and without dextran-conjugated fluorescent dye For the 
first imaging session, blood plasma was labeled with a high concentration of green 
fluorescent dextran-conjugated dye (5% w/v FITC 2 MDa, 52471 Sigma) diluted in 
sterile saline and retro-orbitally injected (100 µl) prior to imaging. A shallow wide-field 
map of the cortical vasculature visible through the cranial window was taken using a 4x 
objective (XLFluor 0.28NA Zeiss). All line scan data, z-stacks above and below 
measured vessels, and z-stacks from the surface of the brain into the deep cortex was 
taken through a higher magnification 25x objective (Olympus XLPlan N 1.05 NA) with 
the 1300nm source and carefully mapped onto the projection of the lower 4x 
magnification map. To identify different vessel classes, we looked at the angle of the 
centerline RBC flow from line-scan measurements with regard to the vessel’s geometric 
structure and branching direction either into or out from the brain [23]. Arterioles and 
venules were determined first, and ascending and descending branches were 
morphologically traced for blood flow measurements. All line scans were performed for 
at least 35 seconds for each individual vessel. Mice recovered for at least one day to 
allow washout of the dextran dye from the circulatory system. The subsequent imaging 
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session used only THG signals for measuring blood flow of all previously examined 
vessels, using the 4x surface map as a guide to relocate them. 
 
5.2.5 Image analysis All image stacks were processed and analyzed using FIJI. Line 
scans were analyzed using a custom written code in MATLAB. 
 
5.3 Results 
To investigate the feasibility of in vivo 3PEF and THG microscopy, we first explored the 
limit of imaging depth. Through a chronic cranial window placed at least 3 weeks prior to 
imaging, we could achieve a depth of ~1mm. In about half of the mice imaged, we could 
go deep into the white matter, ~900µm below the surface (Figure 5.1A). The other half 
had clear imaging up to 830µm in depth. THG produced high contrast of individual blood 
cells in all measured vessels. Deeper into the cortex, line scan analysis was performed on 
capillaries 8µm in diameter or less (Figure 5.1). There was a mild trend of increasing 
blood flow speed and a decrease in the contrast between signal and noise due to 
scattering as a function of depth (Figure 5.1B and C).  
Matching vessels could be identified from previous imaging sessions using the THG 
signal and 4x surface map. In general, the THG signal contrasted well against the 
background throughout the vasculature. Bigger vessels on the surface (diameter >20µm) 
had slightly less THG signal likely due to the absorption of THG by RBCs (Figure 5.2). 
However, these vessels were still identifiable based on the THG signal lining the vessel 
wall. In capillary beds, blood vessel walls do not produce THG signal, and therefore are  
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Figure 5.1 THG and FITC dextran labeled cortical vasculature up to 900µm (A) 3D 
rendering of THG, FITC and merged signals generated by 3PEF. Right panel shows 
examples of individual line scans taken at varying depths. (B) Cell speed in capillaries 
(diameter ~8µm) plotted as function of depth. (C) Signal to noise contrast of each set of 
line scan plotted as function of depth 
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Figure 5.2 Surface cortical vessel imaging with THG and FITC dextran dye (A) 
Images showing thick surface vein (V) and artery (A). (B) Thick vessels exhibit dimmer 
signals in the center due to RBC absorption. All scale bars are 50µm. 
 
identified solely by the THG produced from blood cells within the lumen. Therefore, 
inaccuracies may arise when measuring vessel diameter solely by THG signal. Using 
THG signal to measure vessel diameter produced slightly smaller results compared to 
2PEF-based measurements, since THG signals cannot capture the space between the edge 
of the lumen and blood cells. Another disadvantage of using THG alone to identify 
vessels, is the possibility of missing vessels that do not have sufficient cellular flow due 
to temporary stalls within nearby vessels. THG imaging alone was able to identify all 
vessels previously identified using 3PEF of FITC dextran, except vessels within the white 
matter, where the THG signal from myelin dominated the entire field of view (Figure 
5.4).  
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Figure 5.3 Dextran-conjugated fluorescent dyes caused cortical decreases in blood 
cell speed (A) Example showing measurement of the same vessel in different imaging 
sessions with (right) and without (left) dextran dye (Grey-THG, Green-FITC dextran). 
Scale bar is 10µm. (B) Cortical blood cell speed in different classes of vessels. Green 
dots indicate cell speed measured with FITC dextran (5% 2MDa, 100µl), black dots 
indicate label free cell speed measured by THG without dextran dyes. (C) Measured 
diameter of individual capillaries with FITC dextran using 2PEF and THG. (D) 
Quantitative analysis on percent decrease of blood cell speed due to FITC dextran. (E) 
Difference of cell speed with and without FITC dextran. 
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Figure 5.4 Line scan in the white matter An example of a line scan taken at the level of 
white matter. Scale bars are 50µm. 
 
While measurements were similar in repeated sessions, we observed an overall systemic 
decrease in blood cell speed of ~20% across different classes of vessels (Figure 5.3D and 
E). The decrease may perhaps be due to the high molecular weight dextran. 
 
5.4 Discussion 
In this work, we demonstrated that optical phase-matching THG can provide excellent 
contrast for studying blood flow dynamics in the rodent brain. In the cortex, THG alone 
can function as an alternative to conventional labeling of blood plasma with dextran-
conjugated fluorescent dyes. The sensitivity of THG in brain parenchyma was insightful 
since it also enabled detection of neuronal structures, although the specific neuronal 
subtypes could not be identified.   
 
The use of fluorescent dextran dyes have conventionally been used to label blood plasma 
and to estimate blood cell speed by calculating stripes formed by time displacement of 
blood cells along the vessel lumen. Both the use of THG and 2PEF of FITC dextran gave 
clear alternating stripes in the resulting line scan images. Although THG alone can create 
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excellent signal contrast, accurate measurements of vessel diameter and the ability to 
identify vessels in the white matter may are limited, and still justify the use of dextran-
conjugated dyes.  
Label-free imaging holds many possibilities for various biomedical and clinical 
applications, since the method does not add complexity and associated risks to a system 
by introducing additional contrast agents. In general, most lipid structures possess third 
order susceptibility [15], suggesting the use of THG imaging in more applications than 
simply blood cell imaging, such as tumor detection, neuronal degeneration assessment, 
and progress of demyelination. As a result, THG microscopy may be a promising label-
free tool that can be used in a wide range of applications in the biomedical field. 
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CHAPTER SIX 
 
REDUCTION OF DEEP CORTICAL BLOOD FLOW IN  
APOLIPOPROTEIN 4 MOUSE 
 !
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6.1 Introduction 
Subcortical and periventricular white matter (WM) damage is the major pathological 
hallmark of vascular cognitive impairment and dementia (VCID) and AD [1-7]. However 
the mechanisms underlying disease progression remain unclear [8]. 
ApoE is a lipid transport protein that promotes lipid transport via cell surface receptors 
and is mainly produced by astrocytes, microglia and vascular cells in the brain [2-7]. 
Homozygosity for the ApoE ε4 allele (ε4/ε4) (ApoE4) is known to be correlated to WM 
damage, which underlies both VCID and AD [9-18]. To this date, how ApoE variants 
promote WM injury remains poorly understood. Much work has focused on vascular 
factors since ApoE ε4/ε4 individuals have reduced cerebral blood flow (CBF) and 
cerebrovascular reactivity [15], which could underlie the WM injury. Subcortical and 
periventricular WM is anatomically located at the watershed between separate arterial 
territories with limited collaterals, making WM particularly susceptible to ischemia. 
Furthermore, insufficient blood supply is known to increase susceptibility to ischemic 
injury [8]. Therefore, the reduction of microvascular perfusion in ApoE 4 carriers may 
worsen WM susceptibility to ischemic injury that may underlie cognitive impairment. 
To understand the extent to which cortical and subcortical blood flow is affected with 
ApoE 4 allele modification, we directly measured the blood flow of ApoE 4 mice an 
compaed to mice carrying the human ε3 allele (ε3/ε3) (ApoE3). Furthermore, to mimic 
the pathological condition of reduced perfusion commonly observed in elderly 
populations and various disease states, we reduced brain blood flow using bilateral 
common carotid artery stenosis (BCAS) [19], leading to WM injury.  
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6.2 Methods 
6.2.1 Transgenic animals We used 24 adult mice (3 - 4 month old, male) homozygous 
for a human ApoE3 (as control) or ApoE4 gene targeted replacement of the endogenous 
mouse ApoE gene (12 mice each, B6.129P2-Apoetm2(APOE*3)Mae N8 and B6.129P2-
Apoetm3(APOE*4)Mae N8 from Taconic) [20, 21] . 
 
6.2.2 Chronic cranial imaging window preparation A chronic cranial window was 
prepared using identical procedures as described in Chapter 4. Briefly, a 6-mm diameter 
circular bilateral craniotomy was performed over the parietal cortex on an anesthetized 
mouse. An 8-mm cover slip was attached and the animal was allowed to recover for a 
minimum of three weeks before in vivo imaging and BCAS surgery. All animal 
procedures were approved by the Cornell University Institutional Animal Care and Use 
Committee. 
 
6.2.3 BCAS surgery Diffuse WM injury in the corpus callosum (CC) is induced by 
placing 0.18mm (internal diameter) microcoils on both bilateral common carotid arteries 
as shown in Shibata M. et al. [19]. Briefly, under 1.5~2% isofluorane anesthesia, a 
midline cervical incision is made and both CCAs were exposed and freed from their 
sheaths. Two 4–0 silk sutures were placed around the distal and proximal parts of the 
right CCA. Then, the artery was gently lifted by the sutures and placed between the loops 
of the microcoil just below the carotid bifurcation. The microcoil was twined by rotating 
it around the both CCA, thereby significantly reducing the diameter and compliance of 
the artery. 
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6.2.4 Multiphoton excited fluorescent microscopy Imaging was conducted using a 
custom multiphoton microscope. For 2PEF, a Ti:Sapphire oscillator (Chameleon, 
Coherent) set at 800nm was used. To generate 3PEF with 1300nm laser light, an optical 
parametric amplifier (OPA) (Coherent, Opera-F) was seeded by a diode-pumped 
femtosecond laser (60 µJ/pulse at 1 MHz; Coherent, Monaco). Dispersion for 1,300-nm 
excitation was compensated with an SF11 prism pair [22]. For imaging, the excitation 
laser was scanned with a line rate of ~1kHz with galvanometric scanners. Images were 
acquired with an Olympus XLPlan N 25x 1.05 NA objective. Signal was collected using 
custom detections optics using following emission filters (center wavelength/bandwidth): 
417/60 (THG), 494/41 (FITC) separated with long-pass dichroic with cutoffs at 458nm.  
 
6.2.5 Imaging cortical and subcortical blood flow Mice were anesthetized with 
isofluorane (<1.5% in oxygen) and placed in a stereotaxic apparatus equipped with a 
feedback-controlled heating pad. As above, mice were given atropine sulfate (0.005 
mg/100 g; subcutaneously) to prevent lung secretions. The blood plasma was labeled 
with 2.5% w/v FITC 70 kDa conjugated dextran (Invitrogen) diluted in sterile saline and 
retro-orbitally injected (50 µl) before imaging. For subcortical deep imaging using 
1300nm source, a more concentrated and higher volume FITC dextran (5% w/v, 100µl) 
was used. To quantify blood flow in subcortical vessels, we measured the vessel diameter 
from image stacks and the centerline RBC flow speed from line-scan measurements of 
THG, as described in Santisakultarm T.P. et al [23]. Respiration was monitored 
throughout the imaging session and the isoflurane level was adjusted to maintain a steady 
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breathing rate of ~1 Hz. During the imaging session, mice received an hourly dose of 5% 
w/v glucose in saline (1 ml/100 g) and atropine (0.001 mg/100 g) subcutaneously. All 
images were processed using ImageJ (National Institutes of Health), and blood cell speed 
was calculated by custom written MATLAB code.  
 
6.3 Results 
We used multiphoton imaging to acquire line scans of arterioles and venules on the 
cortical surface, capillaries branching from penetrating arterioles and ascending venules 
in the cortex, and other capillaries deep in the cortex and WM. Vessels were aligned to 
the center of the imaging field, and the speed of blood cells were captured using angled 
stripes as shown in Chapter 5. 
We first measured baseline cortical blood flow in both ApoE 3 (as control) and ApoE 4 
mice. We found no significant differences in cortical blood flow throughout classes of 
different cortical vessels at baseline (Figure 6.1). BCAS surgery was then performed to 
induce an ischemic challenge (to reduce cortical blood flow). After the BCAS procedure, 
there was a trend toward decreased blood flow in cortical vessels in both ApoE 3 and 
ApoE 4 compared to baseline (not statistically significant).  
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Figure 6.1 Cortical blood flow measurements in both ApoE 3 and ApoE 4 before 
and 4 weeks after BCAS surgery Each dot represent individual vessel line scan 
measurements (ApoE 3 n=167 from 4 mice, ApoE 4 n=204 from 4 mice, ApoE 3 4 weeks 
after BCAS n=212 from 7 mice, ApoE 4 4 weeks after BCAS n=220 from 6 mice) !
!
!
Figure 6.2 Quantification of cortical blood flow measurements before and after 
BCAS surgery in both ApoE 3 and ApoE 4 (same data as in Figure 6.1, categorized 
based on their diameter) plotted as mean and SD. 
 
Using a 3PEF laser source (1300-nm excitation) allowed deeper imaging as compared to 
2PEF and enabled us to visualize vessels in the WM (Figure 6.3) [24]. Higher wavelength 
excitation also provided additional structural information produced by THG, that is 
strongly produced by myelinated axons and red blood cells [25, 26]. When using 1300-
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nm excitation, the THG signal was used to measure red blood cell speed instead of a 
fluorescent dextran, since it tends to exhibit superior contrast, as shown in Chapter five.   
We next imaged flow speed of subcortical blood cells (800~1,000 µm from the surface) 
with 3PEF, using the same methods as above. Vessels in the WM are less curved and 
often align with the myelin structure, making it difficult to define vessel branch order. 
However most vessels are capillaries (diameter less than 10µm).  
 
Figure 6.3 3PEF imaging of myelin structure and line scan  (A) Example of capillary 
in the WM of the CC. Fluorescently labeled blood vessels (blue) and WM tracts (yellow, 
imaged via THG) (B) line scan of the capillary shown in A. 
 
For deeper cortical measurement, almost all data were taken on capillaries since the 
majority of vessels in the CC WM were capillaries. Blood flow down in the WM and 
bottom of the cortex were also measured before and 4 wk after BCAS surgery in both 
ApoE 3 and ApoE 4. Blood cell speed in the WM and bottom of the cortex was reduced 
in ApoE 4 mice compared to ApoE 3 counterpart (Figure 6.4). After the BCAS surgery, 
blood flow was further reduced in both ApoE 3 and ApoE 4 expressing mice (Figure 6.4). 
The THG signal could also be used to visualize myelin structure and ultimately correlate 
myelin degeneration with blood flow changes. In the data we collected, we anecdotally  
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Figure 6.4 Reduced blood flow in ApoE 4 mice following BCAS surgery in deep 
cortex Left panel shows subcortical blood flow measurement before and 4 weeks after 
BCAS surgery in both ApoE 3 and ApoE 4. Right panel shows diameter of all the vessels 
measured in the left panel. (ApoE 3 n=81 from 4 mice, ApoE4 n=86 from 4 mice, ApoE 
3 4 week after BCAS n=118 from 4 mice, ApoE 4 4 week after BCAS n=74 from 3 mice, 
* p value <0.005, ** p value <0.0001). 
 
 
Figure 6.5 Myelin structures of ApoE3 and ApoE4 before and 4 weeks after BCAS  
Myelin structures are seen in red, blood vessel labeled with FITC dextran is shown in 
green. All scale bars are 100µm. 
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observed that the myelin seems in the WM seems less thick after BCAS (Figure 6.5, 
differences more evident in image stacks). 
 
6.4 Discussion 
ApoE 4 is known to exacerbate damage in the WM in AD, in which neurodegenerative 
and vascular factors coexist. However, the mechanism underlying how ApoE 4 
negatively impacts the WM, in VCID that occurs in AD, remains unclear. To understand 
to what extent this subcortical blood flow is reduced in ApoE 4 mice without additional 
risk factors in relatively young mice, we directly measured the cell speed in the white 
matter and deep cortex. Although there was no significant change in different classes of 
surface cortical vessels, there was a greater reduction on the blood flow in the WM and 
deep cortex. This supports the possibility that neurovascular dysfunction could cause 
chronic ischemia in the precariously perfused deep WM via ApoE 4 directly affecting 
vital cerebrovascular responses that assure adequate cerebral perfusion.  
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CHAPTER SEVEN 
 
CONCLUTIONS AND FUTURE DIRECTIONS 
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In this final chapter, we will review some of the major conclusions presented in this 
dissertation as well as present topics where future work can be explored. 
 
In chapter 4, we looked at the inflammatory responses after inducing a laser-induced 
microhemorrhage. We observed that the initial response consisted primarily of brain-
resident microglia, which exhibited a coordinated pattern of migration and proliferation 
that led to an increased density of microglia near the lesion (primarily by migration from 
the surrounding tissue), while later recovering the density of microglia in the surrounding 
tissue (by proliferation). Reactive astrocytes were also found near the lesion with a 
similar spatial profile of activation as microglia, but delayed by a few days. Furthermore, 
a small number of invading leukocytes of different phenotypes were also observed, more 
inflammatory monocytes were found in earlier days and patrolling monocytes were found 
in later days. Although the number of invading monocytes was small, these cells were 
present near the lesion for days, perhaps participating in regulating the inflammatory 
response with brain resident glial cells.  
 
In the resting state, microglia and astrocytes support the health and function of various 
neuronal populations in the brain. However, in case of small bleeds, the coordinated 
activation of microglia and astrocyte will occur and likely will drive potentially 
detremental cellular communication through inflammatory cytokines (TNF- α, IL-1β, 
IFN-γ) and chemicals such as ATP and nitric oxide. These signaling molecules are 
known to alter the strength of synaptic connectivity, affect synapse formation, and 
participate in maturation and elimination of neuronal spines, all of which are the 
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fundamental basis of neuronal plasticity. Thus, the inflammatory process we observed 
could, in principle, impact the function and dynamics of neural circuits by modulating 
plasticity. Nevertheless, our previous work with calcium imaging showed microbleeds 
only caused a transient loss of responsiveness to external stimuli that recovered within 4 
hours after the lesion. Because neural activity in response to a peripheral stimulus may 
not be the most sensitive indicator of neural dysfuction, we further looked for more subtle 
changes in neuronal activity. Using transgenic mouse CaMKIItTA-GCamp6s that labels 
only excitatory neuron with a genetically-encoded calcium indicator, we sought for the 
changes in intrinsic firing pattern. 
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Figure 7.1 Intrinsic cellular firing pattern of nearby neurons after laser-induced 
microhemorrhages. (A) Images of CamKIItTA-GCamp6s mouse brain before and after 
the microhemorrhages (red) intravenous injected Texas red labeled blood plasma (green) 
calcium transients induced GFP expression. (B) Temporal profile of calcium transients 
from the cell circled in A. 
  
Mice were under low level of anesthesia (<1.5% of isofluorane in medical air) and only 
the spontaneous calcium activity without any stimulus was recorded. Our preliminary 
data showed that after the onset of a microhemorrhage, excitatory neurons near the lesion 
(within 150 µm around the targeted vessel) had prolonged bursting activity right after the 
bleeding, which continued for about 2 days (Figure 7.1 B second panel). Overall firing 
rate was attenuated but a large population of neuron exhibited prolonged calcium 
transients, likely reflecting tonic bursting. In contrast, we observed increased firing rate 
in neurons in this same region after 7 days (Figure 7.1 B third panel).    
There are many hypothesis as to why tonic bursts happen, including the view that the 
bursts represent a defense mechanism by neurons to overcome synaptic transmission 
failure as the bursts facilitate transmitter release. Inflammatory responses may or may not 
directly trigger these bursts by disrupting precise neurotransmitter delivery or 
phagocytosing synaptic spines. The next step would be looking at the relationship 
between these tonic bursts, or the increased firing rate we observed at later times, and the 
dynamic interaction of inflammatory cells activated by the microhemorrhage with 
neurons.  
The burst firing pattern we observed itself could underlie mild cognitive decline, mood 
disorder, fatigue, and depression reported in patients with CMBs. Accumulation of such 
events and primed glial population not effectively functioning in later life, could underlie 
cognitive decline found in the elderly. It is still hard to find adequate methods to assess 
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mild cognitive decline and mental disorder in both human and animal; many topics 
remain to be explored.  
 
In chapter 5, we explored the possibility of label free blood cell flow measurement. 
Although there were several limitation in measuring diameter with just THG, or imaging 
down at the WM, THG alone was sufficient to find individual vessels of interest, 
determine their branch orders and measure flow speed with conventional line scan 
techniques. We also looked for how much effect a high concentration high molecular 
weight dextran dye affects blood speed. We found a 20% decrease in overall cortical flow 
after injecting 100 µL of 5% 2 MDa FITC dextran in saline. However, the concentration 
typically used is smaller than what we tested, so our findings do not necessarily call into 
question previous work using injected dextrans, but caution is warranted. This work can 
therefore be a nice reference for blood flow measuring community utilizing line-scan 
technique, and development of label free detection tool for clinical use.  
In chapter 6, we showed that ApoE 4 genotype is associated with a significant decrease in 
blood flow in the white matter. In surface cortical vessel we found a trend toward 
decreased blood flow after ischemic stress, however we didn’t see significant statistical 
difference, possibly due to high variation between different orders of vessel branch. 
Furthermore, considering that there weren’t any changes between groups, it does not 
necessarily mean that the overall blood flow is unaffected. There could still be issues 
with changes in vascular network due to capillaries collapsing due to ApoE4 phenotype 
and not be labeled or shown with the tools we used. Therefore, analysis on vascular 
network (number of branches and vessel density) and its structures (tortuosity) along with 
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further assessment on perivascular cellular components that consists different classes of 
vessel may deepen our understanding of changes of blood flow we observed. Moreover, 
myelin degeneration is often found with WM hypertention. The observation on the 
myelin density, functions of glial cells in the WM of ApoE 4 mice will deepen our 
understanding on WM lesion due to ischemic stress of ApoE 4. 
 
 
